☰

Nicole Brufatto, Ph.D. - Publications

Affiliations: 
2003 Queen's University, Canada, Kingston, Ontario, Canada 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Bukys MA, Blum MA, Kim PY, Brufatto N, Nesheim ME, Kalafatis M. Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa. The Journal of Biological Chemistry. 280: 27393-401. PMID 15897196 DOI: 10.1074/Jbc.M503435200  0.613
2004 Dennis MW, Downey C, Brufatto N, Nesheim ME, Stevenson K, Toh CH. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein Thrombosis and Haemostasis. 91: 522-530. PMID 14983228 DOI: 10.1160/Th03-08-0548  0.6
2004 Orfeo T, Brufatto N, Nesheim ME, Xu H, Butenas S, Mann KG. The factor V activation paradox. The Journal of Biological Chemistry. 279: 19580-91. PMID 14982929 DOI: 10.1074/Jbc.M400727200  0.572
2004 Schneider M, Brufatto N, Neill E, Nesheim M. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin. The Journal of Biological Chemistry. 279: 13340-5. PMID 14715654 DOI: 10.1074/Jbc.M313211200  0.608
2003 Brufatto N, Ward A, Nesheim ME. Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex. Journal of Thrombosis and Haemostasis : Jth. 1: 1258-63. PMID 12871328 DOI: 10.1046/J.1538-7836.2003.00254.X  0.609
2003 Brufatto N, Nesheim ME. Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process. The Journal of Biological Chemistry. 278: 6755-64. PMID 12496269 DOI: 10.1074/Jbc.M206413200  0.534
2002 Nesheim M, Samis J, Walker J, Becker L, Brufatto N, Fischer T, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Wenstone R, Downey C, Toh CH. Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients Blood Reviews. 16: S15-22. PMID 12918783  0.548
2002 Toh CH, Samis J, Downey C, Walker J, Becker L, Brufatto N, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Ticknor LO, Paton R, Wenstone R, Nesheim M. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca ++-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation Blood. 100: 2522-2529. PMID 12239165 DOI: 10.1182/Blood.V100.7.2522  0.578
2001 Brufatto N, Nesheim ME. The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation. The Journal of Biological Chemistry. 276: 17663-71. PMID 11278943 DOI: 10.1074/Jbc.M011586200  0.637
Show low-probability matches.